Cancer Research

More Bad News For Tyrosine Kinase Inhibitors- Sunitinib Implicated In Cardiac Toxicity

Another FDA-approved targeted cancer drug, sunitinib (SutentTM, Pfizer), may be associated with cardiac toxicity, report researchers at Children’s Hospital Boston, Dana-Farber Cancer Institute (Boston), and Thomas Jefferson University (Philadelphia). Their ...

Article - News Staff - Dec 14 2007 - 1:19pm

The Complex Path Of Autophagy

Researchers at the University of Massachusetts Medical School, gained new insights into autophagy-- a cellular degradation process associated with a form of programmed cell death-- by studying the salivary gland cells of the fruit fly. Since its initial di ...

Article - News Staff - Dec 14 2007 - 1:46pm

Cellular Natural Selection And Somatic Evolution

Natural selection can occur at the cellular level, where it is detrimental to health. Fortunately it is normally controlled by a well-known pattern of ongoing cell differentiation in the mature tissues of animals, according to a new study published Decembe ...

Article - News Staff - Dec 14 2007 - 3:38pm

New Results From One Of The World's Largest Breast Cancer Trials Offer Hope To Thousands Of Women

LONDON, December 14 /PRNewswire/--- The Benefits of Anastrozole (Arimidex(R)) Over Tamoxifen at Preventing Breast Cancer Recurrence Improve Over Time- Up to Four Years After Treatment Ends New data from ATAC(x), one of the world's largest and longest ...

Article - Anna Ohlden - Dec 15 2007 - 12:26pm

Biochips On Guard

Researchers of the Institute of Molecular Biology, Russian Academy of Sciences, have been working for more than 20 years on designing biological microchips for efficient and quick diagnostics of tuberculosis and other diseases. The BIOCHIP-IMB company was ...

Article - News Staff - Dec 16 2007 - 2:21am

Oxford Genome Sciences And Amgen To Jointly Discover Novel Therapeutic Antibodies In Cancer

OXFORD, England, December 17 /PRNewswire/--- New Deal Provides a Further Opportunity for OGeS to Grow its Therapeutic Antibody Pipeline Oxford Genome Sciences (UK) Ltd "OGeS" announces today that it has entered into a strategic collaboration wit ...

Article - Anna Ohlden - Dec 17 2007 - 2:30am

4SC AG: Management Board And Supervisory Board Publish Statement On The Mandatory Offer Of Santo Holding

PLANEGG-MARTINSRIED, Germany, December 17 /PRNewswire/-- The Management Board and the Supervisory Board of the drug discovery and development company 4SC AG (Frankfurt, Prime Standard: VSC), with its headquarters in Martinsried, Germany, today published t ...

Article - Anna Ohlden - Dec 17 2007 - 3:30am

MammaPrint(R) Breast Cancer Test Shown To Be Powerful Tool For Prognosis Prediction In Postmenopausal Breast Cancer Patients

AMSTERDAM, Netherlands, December 17 /PRNewswire/--- Agendia to file for expanded FDA clearance for MammaPrint(R) Agendia BV, world leader in the rapidly evolving field of molecular diagnostics, announced today that its MammaPrint(R) breast cancer prognosi ...

Article - Anna Ohlden - Dec 17 2007 - 9:30am

Mutated Akt1 Gene Implicated In Atherosclerosis

A genetic mutation expands lesions in the aorta and promotes coronary atherosclerosis, more commonly known as hardening of the arteries, according to a study by Yale School of Medicine in Cell Metabolism. The researchers found that mice engineered without ...

Article - News Staff - Dec 18 2007 - 12:19pm

Cancer Therapeutics CRC And QIMR Collaborate To Discover And Develop Novel Drugs For Cancer Treatment

MELBOURNE, Australia, December 19 /PRNewswire/-- Cancer Therapeutics CRC Pty Ltd and the Queensland Institute of Medical Research (QIMR) today announced a collaboration to discover and develop new drugs for the treatment of many forms of cancer, based on ...

Article - Anna Ohlden - Dec 19 2007 - 3:30am